Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Interleukin-1 receptor-associated kinase 1 [194-712] | ||
Ligand | BDBM348046 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Enzymatic Assay | ||
IC50 | <100±n/a nM | ||
Citation | Jorand-Lebrun, C; Jones, R; Won, AC; Nguyen, N; Johnson, TL; Deselm, LC; Panda, K Heteroaryl compounds as IRAK inhibitors and uses thereof US Patent US9790221 Publication Date 10/17/2017 | ||
More Info.: | Get all data from this article, Assay Method | ||
Interleukin-1 receptor-associated kinase 1 [194-712] | |||
Name: | Interleukin-1 receptor-associated kinase 1 [194-712] | ||
Synonyms: | IRAK | IRAK1 | IRAK1_HUMAN | Interleukin-1 receptor-associated kinase 1 (IRAK1) | ||
Type: | Enzyme Catalytic Domain | ||
Mol. Mass.: | 55943.99 | ||
Organism: | Homo sapiens (Human) | ||
Description: | aa 194-712 | ||
Residue: | 519 | ||
Sequence: |
| ||
BDBM348046 | |||
n/a | |||
Name | BDBM348046 | ||
Synonyms: | US9790221, Compound 254 | ||
Type | Small organic molecule | ||
Emp. Form. | C24H28N8O2S2 | ||
Mol. Mass. | 524.662 | ||
SMILES | Cc1nnc(s1)-c1cnc(nc1N[C@H]1CC[C@@H](CC1)NS(C)(=O)=O)-c1cccc(c1)-c1cnn(C)c1 |r,wU:13.14,wD:16.21,(-6.37,-8.15,;-5.6,-6.81,;-4.06,-6.81,;-3.58,-5.35,;-4.83,-4.44,;-6.07,-5.35,;-4.83,-2.9,;-6.16,-2.13,;-6.16,-.59,;-4.83,.18,;-3.49,-.59,;-3.49,-2.13,;-2.16,-2.9,;-.67,-2.5,;-.27,-1.02,;1.21,-.62,;2.3,-1.71,;1.9,-3.19,;.42,-3.59,;3.79,-1.31,;4.88,-2.4,;5.97,-3.49,;6.37,-2,;4.48,-3.89,;-4.83,1.72,;-6.16,2.49,;-6.16,4.03,;-4.83,4.8,;-3.49,4.03,;-3.49,2.49,;-2.16,4.8,;-.69,4.32,;.21,5.57,;-.69,6.81,;.08,8.15,;-2.16,6.34,)| | ||
Structure |